Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Syneos Health Inc 1030 Sync Street Morrisville NC 27560 USA

www.syneoshealth.com P: 919-876-9300 F: 919-876-9360

Sector:

Medical

INDUSTRY GROUPING:

Medical Information Systems

Description:

Syneos Health, Inc. is a key global biopharmaceutical solutions company offering a broad range of clinical and commercial facilities. The company majorly serves customers in the biopharmaceutical, biotechnology and medical device industries. Through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), it provides integrated and self-contained biopharmaceutical product development solutions varying from Early Phase (Phase I) clinical trials to complete commercialization of biopharmaceutical products.

Key Statistics

Overview:

Market Capitalization, $K 4,457,843
Enterprise Value, $K 6,957,013
Shares Outstanding, K 103,719
Float, K 103,366
% Float 99.66%
Short Volume Ratio 0.34
% of Insider Shareholders 0.34%
% of Institutional Shareholders 91.16%

Financials:

Annual Sales, $ 5,393 M
Annual Net Income, $ 266,500 K
Last Quarter Sales, $ 1,366 M
Last Quarter Net Income, $ 790 K
EBIT, $ 460,060 K
EBITDA, $ 707,240 K

Growth:

1-Year Return -7.57%
3-Year Return -23.06%
5-Year Return -10.61%
5-Year Revenue Growth 101.83%
5-Year Earnings Growth 121.65%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 08/08/23
Next Earnings Date 11/02/23
Earnings Per Share ttm 2.89
EPS Growth vs. Prev Qtr -98.33%
EPS Growth vs. Prev Year -99.12%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SYNH Ratios

Ratio
Price/Earnings ttm 14.87
Price/Earnings forward 15.40
Price/Earnings to Growth N/A
Return-on-Equity % 8.63%
Return-on-Assets % 3.66%
Profit Margin % 4.94%
Debt/Equity 0.77
Price/Sales 0.83
Price/Cash Flow 6.40
Price/Book 1.28
Book Value/Share 33.69
Interest Coverage 4.82
60-Month Beta 1.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar